Cargando…

Menopausal hormone therapy and breast cancer risk: All progestogens are not the same

Detalles Bibliográficos
Autor principal:	Lambrinoudaki, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Invited Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683312/ https://www.ncbi.nlm.nih.gov/pubmed/33294389 http://dx.doi.org/10.1016/j.crwh.2020.e00270

Ejemplares similares

Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015)

Menopausal hormone therapy and ovarian cancer
por: Baber, Rod
Publicado: (2015)

Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
por: Deng, Yu, et al.
Publicado: (2022)

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
por: Stevenson, John C, et al.
Publicado: (2020)

Postmenopausal bleeding: Which endometrial thickness is safe in menopausal hormone therapy users?
por: Dreisler, Eva
Publicado: (2022)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

Menopausal hormone therapy for women with obesity in the era of COVID-19
por: Paschou, Stavroula A., et al.
Publicado: (2020)

Talking about menopause in the workplace
por: Carter, Sarah, et al.
Publicado: (2021)

Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen
por: Canonico, Marianne, et al.
Publicado: (2016)

Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022)

Menopause-associated risk of cardiovascular disease
por: Anagnostis, Panagiotis, et al.
Publicado: (2022)

Menopause and personal protective equipment: How does this meet acceptable working conditions?
por: Kydd, Angela
Publicado: (2021)

Is There Any Fun in a Puzzle When All Pieces Look the Same?
por: Behrendt, Christian-Alexander
Publicado: (2023)

Menopausal hormone therapy after breast cancer
por: Colditz, Graham A
Publicado: (2005)

Menopause, androgens, and cardiovascular ageing: a narrative review
por: Armeni, Eleni, et al.
Publicado: (2022)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)

The clinical relevance of progestogens in hormonal contraception: Present status and future developments
por: Regidor, Pedro-Antonio
Publicado: (2018)

Neuroprotection of reduced thyroid hormone with increased estrogen and progestogen in postpartum depression
por: Li, Dan, et al.
Publicado: (2019)

Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
por: Bińkowska, Małgorzata, et al.
Publicado: (2022)

Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
por: Beral, Valerie, et al.
Publicado: (2011)

Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
por: Jones, Michael E, et al.
Publicado: (2016)

The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan
por: Liu, Jui-Yao, et al.
Publicado: (2016)

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013)

The Role of Menopausal Hormone Therapy in Reducing All-cause Mortality in Postmenopausal Women Younger than 60 Years: An Adaptive Meta-analysis
por: Bae, Jong-Myon, et al.
Publicado: (2018)

COVID-19 and hormonal contraception
por: Cagnacci, Angelo, et al.
Publicado: (2022)

Menopause Hormone Therapy in the Changing Trends of Breast Cancer in India
por: Meeta, Meeta, et al.
Publicado: (2020)

Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease.
por: Plu-Bureau, G., et al.
Publicado: (1994)

San Antonio Breast Cancer Symposium 2007—Adjuvant endocrine therapy update: ATAC 100 highlights
por: Joy, Anil A.
Publicado: (2008)

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
por: Rozenberg, S., et al.
Publicado: (2020)

Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible
por: Banks, Emily, et al.
Publicado: (2010)

Menopausal Hormone Therapy, can we safely use it in women with co-morbidities?
por: Shah, Duru
Publicado: (2015)

Use of novel drug therapies during pregnancy and breast-feeding
por: Ayuk, Paul T.-Y.
Publicado: (2023)

Bridging progestogens in pregnancy and pregnancy prevention
por: Micks, Elizabeth, et al.
Publicado: (2015)

Risk of Breast Cancer by Type of Menopausal Hormone Therapy: a Case-Control Study among Post-Menopausal Women in France
por: Cordina-Duverger, Emilie, et al.
Publicado: (2013)

Conclusions about testosterone therapy and cardiovascular risk
por: Anawalt, Bradley D, et al.
Publicado: (2018)

Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer
por: Thomas, Cecilia E., et al.
Publicado: (2022)

The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage
por: Arab, Hisham, et al.
Publicado: (2019)

Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?
por: Xia, Zhi, et al.
Publicado: (2021)

The Pursuit of Originality Makes Us All the Same!
por: Sogi, G M
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_amntubndn5370bfmqmf2j566pi